Cited by 567Cannabis and Cannabinoid ResearchSchizophrenia research and treatmentForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

High-potency cannabis and the risk of psychosis

Open access

Di Forti, Marta, Morgan, Craig, Dazzan, Paola, Pariante, Carmine, Mondelli, Valeria, Marques, Tiago Reis, Handley, Rowena, Luzi, Sonija, Russo, Manuela, Paparelli, Alessandra, Butt, Alexander, Stilo, Simona A., Wiffen, Ben, Powell, John, Murray, Robin M.·2009·British Journal of Psychiatry

DOI 10.1192/bjp.bp.109.064220PMC PMC2801827

Open this paper in CoChat — free account Open PDF

Abstract

Background: People who use cannabis have an increased risk of psychosis an effect attributed to the active ingredient δ9-tetrahydrocannabinol (Δ9-THC). There has recently been concern over an increase in the concentration of Δ9-THC in the cannabis available in many countries. Aims: To investigate whether people with a first episode of psychosis were particularly likely to use high-potency cannabis. Method: We collected information on cannabis use from 280 cases presenting with a first episode of psychosis to the South London & Maudsley National Health Service (NHS) Foundation Trust, and from 174 healthy controls recruited from the local population. Results: There was no significant difference between cases and controls in whether they had ever taken cannabis, or age at first use. However, those in the cases group were more likely to be current daily users (OR = 6.4) and to have smoked cannabis for more than 5 years (OR = 2.1). Among those who used cannabis, 78% of the cases group used high-potency cannabis (sinsemilla, ‘skunk’) compared with 37% of the control group (OR 6.8). Conclusions: The finding that people with a first episode of psychosis had smoked higher-potency cannabis, for longer and with greater frequency, than a healthy control group is consistent with the hypothesis that Δ9-THC is the active ingredient increasing risk of psychosis. This has important public health implications, given the increased availability and use of high-potency cannabis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.109.064220

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Psychosis Screening Questionnaire
Bebbington, P., & Nayani, T. (1995) · PsycTESTS Dataset · doi:10.1037/t30040-000 · Cited by 546
From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis
Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.003 · Cited by 512
The Environment and Schizophrenia: The Role of Cannabis Use
Henquet, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi027 · Cited by 468
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2253 · Cited by 329
Self-citation
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Self-citation
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Bossong, M., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R., Windhorst, A., van Gerven, J. V., Ramsey, N., Lammertsma, A., & Kahn, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 262
Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*
Potter, D. J., Clark, P., & Brown, M. B. (2008) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00603.x · Cited by 230
Cannabis-Induced Psychosis-Like Experiences Are Associated with High Schizotypy
Barkus, E., Stirling, J., Hopkins, R., & Lewis, S. W. (2006) · Psychopathology · doi:10.1159/000092678 · Cited by 170

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 5

2005, The Classification of Cannabis under the Misuse of Drugs Act 1971
1992, Schedules for Clinical Assessment in Neuropsychiatry (SCAN)
1992, The ICD–10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines
British Crime Survey, 2006–2007
Hardwick, 2008, Home Office Cannabis Potency Study

Sorted by citations

Items 101–200 of 563

Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls
Trotta, A., Forti, M. D., Mondelli, V., Dazzan, P., Pariante, C. M., David, A. S., Mulè, A., Ferraro, L., Formica, I., Murray, R. M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.001 · Cited by 85
Self-citation
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users
Morgan, C. J. A., Noronha, L. A., Muetzelfeldt, M., Feilding, A., & Curran, H. V. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113477744 · Cited by 92
Self-citation
Heterogeneity in the composition of marijuana seized in California
Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.031 · Cited by 81
Mental Health–related Emergency Department Visits Associated With Cannabis in Colorado
Hall, K. E., Monte, A. A., Chang, T., Fox, J. A., Brevik, C., Vigil, D. I., Dyke, M. V. V., & James, K. A. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13393 · Cited by 81
Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
Colizzi, M., Iyegbe, C. O., Powell, J. F., Ursini, G., Porcelli, A., Bonvino, A., Taurisano, P., Romano, R., Masellis, R., Blasi, G., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv032 · Cited by 80
Self-citation
Identifying aspects of neighbourhood deprivation associated with increased incidence of schizophrenia
Bhavsar, V., Boydell, J. E., Murray, R. M., & Power, P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.014 · Cited by 80
Self-citation
Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta‐analysis
Carney, R., Cotter, J., Firth, J., Bradshaw, T., & Yung, A. R. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12699 · Cited by 79
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
Gage, S. H., Zammit, S., & Hickman, M. (2013) · F1000 Medicine Reports · doi:10.3410/m5-2 · Cited by 78
Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC
Kruger, D. J., & Kruger, J. S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0124 · Cited by 77
Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
Clausen, L., Hjorthøj, C. R., Thorup, A. A. E., Jeppesen, P., Petersen, L., Bertelsen, M., & Nordentoft, M. (2013) · Psychological Medicine · doi:10.1017/s0033291713000433 · Cited by 75
Further evidence of a cumulative effect of social disadvantage on risk of psychosis
Stilo, S. A., Gayer-Anderson, C. E., Beards, S., Hubbard, K., Onyejiaka, A. N., Keraite, A., Borges, S., Mondelli, V., Dazzan, P., Pariante, C. M., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716002993 · Cited by 75
Self-citation
The association between cannabis abuse and subsequent schizophrenia: A Swedish national co-relative control study
Giordano, G. N., Ohlsson, H., Sundquist, K., Sundquist, J., & Kendler, K. S. (2015) · Psychological Medicine · doi:10.1017/s0033291714001524 · Cited by 74
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
van der Steur, S. J., Batalla, A., & Bossong, M. G. (2020) · Brain Sciences · doi:10.3390/brainsci10020097 · Cited by 78
Cannabis regulatory science: risk–benefit considerations for mental disorders
Borodovsky, J. T., & Budney, A. J. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1454406 · Cited by 75
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Flack, N., Colwell, M., Drown, C., & Faulk, C. D. (2021) · Clinical Epigenetics · doi:10.1186/s13148-020-00993-4 · Cited by 72
Marijuana use trajectories during college predict health outcomes nine years post-matriculation.
Arria, A. M., Caldeira, K. M., Bugbee, B. A., Vincent, K. B., & O’Grady, K. E. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.009 · Cited by 71
Neighbourhood characteristics and the incidence of first-episode psychosis and duration of untreated psychosis
O'Donoghue, B. N., Lyne, J., Renwick, L., Lane, A., Madigan, K. V., Staines, A. S., O’Callaghan, E., & Clarke, M. (2016) · Psychological Medicine · doi:10.1017/s003329171500286x · Cited by 70
Social Disadvantage: Cause or Consequence of Impending Psychosis?
Stilo, S. A., Forti, M. D., Mondelli, V., Falcone, A. M., Russo, M., O’Connor, J. A., Palmer-Cooper, E. C., Paparelli, A., Kolliakou, A., Sirianni, M., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs112 · Cited by 69
Self-citation
Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study
Trotta, A., Iyegbe, C. O., Forti, M. D., Sham, P. C., Campbell, D., Cherny, S. S., Mondelli, V., Aitchison, K. J., Murray, R. M., Vassos, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163319 · Cited by 69
Self-citation
Endocannabinoids and Mental Disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 72
Violence and Cannabis Use: A Focused Review of a Forgotten Aspect in the Era of Liberalizing Cannabis
Dellazizzo, L., Potvin, S., Athanassiou, M., & Dumais, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.567887 · Cited by 72
What can we learn about schizophrenia from studying the human model, drug‐induced psychosis?
Murray, R. M., Paparelli, A., Morrison, P. D., Marconi, A., & Forti, M. D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32177 · Cited by 72
Self-citation
Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment
Zuelli, F. M. D. G. C., Loureiro, C. M., Shuhama, R., Fachim, H., Menezes, P. R., Louzada‐Júnior, P., Mondelli, V., & Del‐Ben, C. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001016 · Cited by 66
Self-citation
Impact of childhood adversities on specific symptom dimensions in first-episode psychosis
Ajnakina, O., Trotta, A., Oakley-Hannibal, E., Forti, M. D., Stilo, S. A., Kolliakou, A., Gardner-Sood, P., Gaughran, F., David, A. S., Dazzan, P., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001816 · Cited by 65
Self-citation
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
Marco, E. M., & Laviola, G. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 67
Why do patients with psychosis use cannabis and are they ready to change their use?
Kolliakou, A., Joseph, C., Ismail, K., Atakan, Z., & Murray, R. M. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.11.006 · Cited by 65
Self-citation
Physicians and Medical Marijuana
Kleber, H. D., & DuPont, R. L. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030373 · Cited by 65
Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
Wainberg, M., Jacobs, G. R., Forti, M. D., & Tripathy, S. J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01330-w · Cited by 68
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Haney, M., & Evins, A. E. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.251 · Cited by 67
Psychosis‐inducing effects of cannabis are related to both childhood abuse and COMT genotypes
Alemany, S., Arias, B., Fatjó‐Vilas, M., Villa, H., Moya-Higueras, J., Ibáñez, M. I., Ortet, G., Gastó, C., & Fañanás, L. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12108 · Cited by 68
Cannabis users have higher premorbid IQ than other patients with first onset psychosis
Ferraro, L., Russo, M., O’Connor, J. A., Wiffen, B. D. R., Falcone, M. A., Sideli, L., Gardner-Sood, P., Stilo, S. A., Trotta, A., Dazzan, P., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.046 · Cited by 63
Self-citation
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., Kornhuber, J., Quednow, B. B., & Müller, C. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00152 · Cited by 73
Definitions of Risky and Problematic Cannabis Use: A Systematic Review
Casajuana, C., López‐Pelayo, H., Balcells‐Oliveró, M., Miquel, L., Colom, J., & Gual, A. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1197266 · Cited by 64
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Sorkhou, M., Bedder, R. H., & George, T. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630247 · Cited by 61
Cannabis Concentrate Use in Adolescents
Meier, M. H., Docherty, M., Leischow, S. J., Grimm, K. J., & Pardini, D. A. (2019) · PEDIATRICS · doi:10.1542/peds.2019-0338 · Cited by 61
Advancing the science on cannabis concentrates and behavioural health
Bidwell, L. C., Martin‐Willett, R., & Karoly, H. C. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13281 · Cited by 60
Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study
Ricci, V., Ceci, F., Carlo, F. D., Lalli, A., Ciavoni, L., Mosca, A., Sepede, G., Salone, A., Quattrone, D., Fraticelli, S., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109118 · Cited by 62
Effect of high-potency cannabis on corpus callosum microstructure
Rigucci, S., Marques, T. R., Forti, M. D., Taylor, H., Dell’Acqua, F., Mondelli, V., Bonaccorso, S., Simmons, A., David, A. S., Girardi, P., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002342 · Cited by 59
Self-citation
Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status
Rup, J., Freeman, T. P., Perlman, C., & Hammond, D. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106991 · Cited by 59
Epidemiology of adolescent substance use in London schools
Penney, J., Dargan, P. I., Padmore, J., Wood, D. M., & Norman, I. J. (2015) · QJM · doi:10.1093/qjmed/hcv171 · Cited by 59
Migration history and risk of psychosis: results from the multinational EU-GEI study
Tarricone, I., D’Andrea, G., Jongsma, H. E., Tosato, S., Gayer-Anderson, C. E., Stilo, S. A., Suprani, F., Iyegbe, C. O., van der Ven, E., Quattrone, D., et al. (2021) · Psychological Medicine · doi:10.1017/s003329172000495x · Cited by 61
Self-citation
Developmental Effects of Cannabinoids on Zebrafish Larvae
Akhtar, M. T., Ali, S., Rashidi, H., van der Kooy, F., Verpoorte, R., & Richardson, M. K. (2013) · Zebrafish · doi:10.1089/zeb.2012.0785 · Cited by 59
Framework for sex differences in adolescent neurobiology: A focus on cannabinoids
Viveros, M., Marco, E. M., López‐Gallardo, M., García‐Segura, L. M., & Wagner, E. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.005 · Cited by 59
Cannabis for Therapeutic Purposes and public health and safety: A systematic and critical review
Sznitman, S. R., & Zolotov, Y. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.09.005 · Cited by 57
Cannabis use and first manic episode
Bally, N., ZULLINO, D. F., & Aubry, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.038 · Cited by 59
The impacts of potency, warning messages, and price on preferences for Cannabis flower products
Shi, Y., Cao, Y., Shang, C., & Pacula, R. L. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.07.037 · Cited by 60
Cannabinoids as hippocampal network administrators
Lupica, C. R., Hu, Y., Devinsky, O., & Hoffman, A. F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.003 · Cited by 55
Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
Deiana, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1425 · Cited by 54
Regular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: Results from a complementary meta-analysis
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.026 · Cited by 56
First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation
Ricci, V., Ceci, F., Carlo, F. D., Muzio, I. D., Ciavoni, L., Santangelo, M., Salvo, G. D., Pettorruso, M., Martinotti, G., & Maina, G. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115053 · Cited by 52
NPS: Medical Consequences Associated with Their Intake
Schifano, F., Orsolini, L., Papanti, D., & Corkery, J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_15 · Cited by 56
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
Pennypacker, S. D., Cunnane, K., Cash, M. C., & Romero-Sandoval, E. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921493 · Cited by 58
Drugs of abuse and increased risk of psychosis development
Gururajan, A., Manning, E. E., Klug, M., & van den Buuse, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412455232 · Cited by 50
CBD and THC: Do They Complement Each Other Like Yin and Yang?
Pennypacker, S. D., & Romero-Sandoval, E. A. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2469 · Cited by 54
Identifying Patients With Problematic Drug Use in the Emergency Department: Results of a Multisite Study
Macias‐Konstantopoulos, W., Dreifuss, J. A., McDermott, K. A., Parry, B. A., Howell, M. L., Mandler, R. N., Fitzmaurice, G. M., Bogenschutz, M. P., & Weiss, R. D. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2014.05.012 · Cited by 49
Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review
Farris, M. S., Shakeel, M. K., & Addington, J. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01810-x · Cited by 49
What every adolescent needs to know: Cannabis can cause psychosis
Shapiro, G. K., & Buckley-Hunter, L. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.04.002 · Cited by 48
Endocannabinoid system: Potential novel targets for treatment of schizophrenia
Saito, A., Ballinger, M. D., Pletnikov, M. V., Wong, D. F., & Kamiya, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.020 · Cited by 47
Barriers to participation in mental health research: Findings from the Genetics and Psychosis (GAP) Study
Woodall, A., Howard, L. M., & Morgan, C. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2010.546777 · Cited by 47
Self-citation
Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up
Brandizzi, M., Valmaggia, L., Byrne, M., Jones, C., Iwegbu, N., Badger, S., McGuire, P. K., & Fusar‐Poli, P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.005 · Cited by 55
Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration?
Lorenzetti, V., Alonso-Lana, S., Youssef, G. J., Verdejo‐García, A., Suo, C., Cousijn, J., Takagi, M., Yücel, M., & Solowij, N. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160805155922 · Cited by 48
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
Leweke, F. M., Mueller, J. K., Lange, B., Fritze, S., Topor, C. E., Koethe, D., & Rohleder, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0539-z · Cited by 48
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Velthorst, E., Mollon, J., Murray, R. M., de Haan, L., Myin‐Germeys, I., Glahn, D. C., Arango, C., van der Ven, E., Forti, M. D., Bernardo, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00969-z · Cited by 50
Self-citation
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Pintori, N., Caria, F., Luca, M. A. D., & Miliano, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065251 · Cited by 50
Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis
Theleritis, C. G., Fisher, H. L., Shäfer, I., Winters, L., Stahl, D. R., Morgan, C., Dazzan, P., Breedvelt, J., Sambath, I., Vitoratou, S., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.013 · Cited by 46
Self-citation
The association between cannabis use and suicidality among men and women: A population-based longitudinal study
Shalit, N., Shoval, G., Shlosberg, D., Feingold, D., & Lev‐Ran, S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.010 · Cited by 47
Clearing the haze: the complexities and challenges of research on state marijuana laws
Choo, E. K., & Emery, S. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13093 · Cited by 46
Medical cannabis in the UK: From principle to practice
Schlag, A. K., Baldwin, D. S., Barnes, M., Bazire, S., Coathup, R., Curran, H. V., McShane, R. H., Phillips, L. D., Singh, I., & Nutt, D. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120926677 · Cited by 49
BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction
Segal‐Gavish, H., Gazit, N., Barhum, Y., Ben‐Zur, T., Taler, M., Hornfeld, S. H., Gil‐Ad, I., Weizman, A., Slutsky, I., Niwa, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx139 · Cited by 45
First-episode psychosis at the West Bologna Community Mental Health Centre: results of an 8-year prospective study
Tarricone, I., Mimmi, S., Paparelli, A., Rossi, E., Mori, E., Panigada, S., Carchia, G., Bandieri, V., Michetti, R., Minenna, G., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712000335 · Cited by 45
Self-citation
The Impact of Cannabis Use on Clinical Outcomes in Recent Onset Psychosis
Barrowclough, C., Gregg, L., Lobban, F. A., Bucci, S., & Emsley, R. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu095 · Cited by 44
Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine
Bergamaschi, M. M., Barnes, A. J., Queiróz, R. H. C., Hurd, Y. L., & Huestis, M. A. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-6837-x · Cited by 43
Cannabis Use and Mental Health: A Review of Recent Epidemiological Research
Richardson, T. H. (2010) · International Journal of Pharmacology · doi:10.3923/ijp.2010.796.807 · Cited by 43
The behavioral profile of spice and synthetic cannabinoids in humans
Müller, H., Kornhuber, J., & Sperling, W. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.10.013 · Cited by 42
Synthetic delta‐9‐tetrahydrocannabinol elicits schizophrenia‐like negative symptoms which are distinct from sedation
Morrison, P. D., & Stone, J. M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1166 · Cited by 42
Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients
Ajnakina, O., Trotta, A., Forti, M. D., Stilo, S. A., Kolliakou, A., Gardner-Sood, P., López-Moríñigo, J.-D., Gaughran, F., David, A. S., Dazzan, P., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.054 · Cited by 42
Self-citation
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
Ballinger, M. D., Saito, A., Abazyan, B. N., Taniguchi, Y., Huang, C.-H., Ito, K., Zhu, X., Segal‐Gavish, H., Jaaro-Peled, H., Sawa, A., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.006 · Cited by 42
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
Scherma, M., Masia, P., Deidda, M. L., Fratta, W., Tanda, G., & Fadda, P. (2018) · Medicines · doi:10.3390/medicines5040107 · Cited by 43
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Carvalho, A. C., & Vieira‐Coelho, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106258 · Cited by 42
Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use
Sideli, L., Fisher, H. L., Murray, R. M., Sallis, H., Russo, M., Stilo, S. A., Paparelli, A., Wiffen, B. D. R., O’Connor, J. A., Pintore, S., et al. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12285 · Cited by 40
Self-citation
GRIN2B Promoter Methylation Deficits in Early-Onset Schizophrenia and its Association with Cognitive Function
Fachim, H., Loureiro, C. M., Zuelli, F. M. D. G. C., Shuhama, R., Louzada‐Júnior, P., Menezes, P. R., Dalton, C., Del‐Ben, C. M., & Reynolds, G. P. (2019) · Epigenomics · doi:10.2217/epi-2018-0127 · Cited by 40
Cannabinoids determination in oral fluid by SPME–GC/MS and UHPLC–MS/MS and its application on suspected drivers
Anzillotti, L., Castrignanò, E., Rossi, S. S., & Chiarotti, M. (2014) · Science & Justice · doi:10.1016/j.scijus.2014.08.004 · Cited by 40
Duration of untreated psychosis in adolescents: Ethnic differences and clinical profiles
Dominguez, M.-D.-G., Fisher, H. L., Major, B., Chisholm, B., Rahaman, N., Joyce, J., Woolley, J., Lawrence, J., Hinton, M., Marlowe, K., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.018 · Cited by 39
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
Hudson, R., Rushlow, W. J., & Laviolette, S. R. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4766-7 · Cited by 40
Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression
López-Moríñigo, J.-D., Forti, M. D., Ajnakina, O., Wiffen, B. D. R., Morgan, K. D., Doody, G. A., Jones, P. B., Ayesa‐Arriola, R., Canal‐Rivero, M., Crespo‐Facorro, B., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.016 · Cited by 42
Self-citation
Differential gene expression analysis in blood of first episode psychosis patients
Leirer, D. J., Iyegbe, C. O., Forti, M. D., Patel, H., Carra, E., Fraietta, S., Colizzi, M., Mondelli, V., Quattrone, D., Lally, J., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.05.011 · Cited by 41
Self-citation
Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study
Myran, D. T., Brown, C. R. L., & Tanuseputro, P. (2019) · CMAJ Open · doi:10.9778/cmajo.20190012 · Cited by 39
Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis
Vieira, S., Gong, Q., Scarpazza, C., Lui, S., Huang, X., Crespo‐Facorro, B., Tordesillas‐Gutiérrez, D., de la Foz, V. O., Setién‐Suero, E., Scheepers, F. E., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719003568 · Cited by 36
Self-citation
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study
Murray, R. M., Mondelli, V., Stilo, S. A., Trotta, A., Sideli, L., Ajnakina, O., Ferraro, L., Vassos, E., Iyegbe, C. O., Schoeler, T., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.011 · Cited by 40
Self-citation
Cannabinoids and their therapeutic applications in mental disorders
Scherma, M., Muntoni, A. L., Riedel, G., Fratta, W., & Fadda, P. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/pfadda · Cited by 38
Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of Δ 9 -tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
Tunbridge, E. M., Dunn, G., Murray, R. M., Evans, N., Lister, R., Stumpenhorst, K., Harrison, P. J., Morrison, P. D., & Freeman, D. H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609073 · Cited by 37
Self-citation
Adverse effects of heavy cannabis use: Even plants can harm the brain
Sideli, L., Trotta, G., Spinazzola, E., La Cascia, C., & Di Forti, M. (2021) · Pain · doi:10.1097/j.pain.0000000000001963 · Cited by 36
Orbitofrontal connectivity is associated with depression and anxiety in marijuana-using adolescents
Subramaniam, P., Rogowska, J., DiMuzio, J. M., Lopez-Larson, M. P., McGlade, E., & Yurgelun-Todd, D. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.002 · Cited by 33
Perceived racial and social class discrimination and cannabis involvement among Black youth and young adults
Ahuja, M., Haeny, A. M., Sartor, C. E., & Bucholz, K. K. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109304 · Cited by 35
Differences in cannabis-related experiences between patients with a first episode of psychosis and controls
Bianconi, F., Bonomo, M., Marconi, A., Kolliakou, A., Stilo, S. A., Iyegbe, C. O., Muñoz, P. G., Homayoun, S., Mondelli, V., Luzi, S., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002494 · Cited by 34
Self-citation
Association of Substance Use Disorders With Conversion From Schizotypal Disorder to Schizophrenia
Hjorthøj, C. R., Albert, N., & Nordentoft, M. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0568 · Cited by 34
Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
Gabaglio, M., Zamberletti, E., Manenti, C., Parolaro, D., & Rubino, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168899 · Cited by 34
Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms
Ricci, V., Martinotti, G., Ceci, F., Chiappini, S., Carlo, F. D., Burkauskas, J., Susini, O., Luciani, D., Quattrone, D., Berardis, D. D., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312632 · Cited by 34
Has the intake of THC by cannabis users changed over the last decade? Evidence of increased exposure by analysis of blood THC concentrations in impaired drivers
Vindenes, V., Strand, D. H., Kristoffersen, L., Boix, F., & Mørland, J. G. (2013) · Forensic Science International · doi:10.1016/j.forsciint.2013.01.017 · Cited by 34
Common Substances of Abuse
Wang, G. S., & Hoyte, C. O. (2018) · Pediatrics in Review · doi:10.1542/pir.2017-0267 · Cited by 33

Authors: Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S. A., Wiffen, B., Powell, J., & Murray, R. M.
Affiliations: Springfield University Hospital (GB)
ORCID: Morgan, Craig
Dazzan, Paola
Pariante, Carmine
Mondelli, Valeria
Marques, Tiago Reis
Luzi, Sonija
Russo, Manuela
Powell, John
Murray, Robin M.
Venue: British Journal of Psychiatry
Publisher: Royal College of Psychiatrists
Published: 2009-12
Volume: 195
Issue: 6
Pages: 488-491
ISSN: 0007-1250 (ISSN-L)
1472-1465
DOI: 10.1192/bjp.bp.109.064220
PMC: PMC2801827
OpenAlex: W2104532446
Cited by: 567
References: 15
Citations by year: 2026: 10 · 2025: 11 · 2024: 25 · 2023: 30 · 2022: 38 · 2021: 41 · 2020: 54 · 2019: 31 · 2018: 35 · 2017: 38 · 2016: 46 · 2015: 36 · 2014: 28 · 2013: 36 · 2012: 29
FWCI: 25.87
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified, 2954 d)
Locations: The British Journal of Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: King's College London
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: high-potency cannabis, psychosis, first-episode psychosis, delta-9-tetrahydrocannabinol, cannabis use, daily cannabis use, public health implications
MeSH terms: Adolescent, Adult, Age Factors, Aged, Cannabis, Female, Humans, London, Male, Marijuana Smoking, Middle Aged, Psychoses, Substance-Induced, Risk Factors, Dronabinol, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-potency cannabis and the risk of psychosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks